Quick Takeaways
- Advent Life Sciences LLP filed SCHEDULE 13G/A for Aura Biosciences, Inc. Common Stock, par value $0.00001 per share (AURA).
- Disclosed ownership: 3.3%.
- Date of event: 13 Feb 2026.
Advent Life Sciences LLP - 13 Feb 2026 SCHEDULE 13G/A Report for Aura Biosciences, Inc. Common Stock, par value $0.00001 per share (AURA)
- Filing Manager
- Advent Life Sciences LLP
- Reporting Manager
- Rajesh Parekh, Ph.D.
- Symbol
- AURA
- Shares outstanding
- 62,124,648 shares
- Disclosed Ownership
- 2,071,857 shares
- Ownership
- 3.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 20:48:03 UTC
- Date of event
- 13 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Advent Life Sciences LLP disclosed 3.3% ownership in Aura Biosciences, Inc. Common Stock, par value $0.00001 per share (AURA) on 13 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 20:48.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (6)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Advent Life Sciences LLP | 3.3% | 2,023,857 | 0 | 2,023,857 | /s/Rajesh Parekh, Ph.D. | General Partner of Advent Life Sciences LLP | |
| Advent Life Sciences Fund I LP | 3.3% | 2,023,857 | 0 | 2,023,857 | /s/Rajesh Parekh, Ph.D. | General Partner of Advent Life Sciences LLP acting in its capacity as Manager of Advent Life Sciences Fund I LP | |
| Rajesh Parekh, Ph.D. | 3.3% | 2,071,857 | 0 | 2,023,857 | /s/Rajesh Parekh, Ph.D. | /s/Rajesh Parekh, Ph.D. | |
| Advent Life Sciences Fund III LP | 3.3% | 2,023,857 | 0 | 2,023,857 | /s/Rajesh Parekh, Ph.D. | General Partner of Advent Life Sciences LLP acting in its capacity as Manager of Advent Life Sciences Fund III LP | |
| ALS III Carry and Co-Invest LP | 3.3% | 2,023,857 | 0 | 2,023,857 | /s/Rajesh Parekh, Ph.D. | General Partner of Advent Life Sciences LLP acting in its capacity as Manager of ALS III Carry and Co-Invest LP | |
| Advent-Harrington Impact Fund LP | 3.3% | 2,023,857 | 0 | 2,023,857 | /s/Rajesh Parekh, Ph.D. | General Partner of Advent Life Sciences LLP acting in its capacity as Manager of Advent-Harrington Impact Fund LP |